<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pediatr Nephrol</journal-id>
      <journal-title-group>
        <journal-title>Pediatric Nephrology (Berlin, Germany)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0931-041X</issn>
      <issn pub-type="epub">1432-198X</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20652819</article-id>
      <article-id pub-id-type="pmc">2991236</article-id>
      <article-id pub-id-type="publisher-id">1608</article-id>
      <article-id pub-id-type="doi">10.1007/s00467-010-1608-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editors</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Davin</surname>
            <given-names>Jean-Claude</given-names>
          </name>
          <address>
            <phone>+31-20-5669111</phone>
            <email>j.c.davin@amc.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Majoie</surname>
            <given-names>Charles</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Groothoff</surname>
            <given-names>Jaap</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gracchi</surname>
            <given-names>Valentina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bouts</surname>
            <given-names>Antonia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Goodship</surname>
            <given-names>Timothy H. J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Loirat</surname>
            <given-names>Chantal</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Pediatric Nephrology Department, Emma Children&#x2019;s Hospital-Academic Medical Center, Meibergdreef 9, AZ 1105 Amsterdam, ZO The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Department of Radiology, Academic Medical Centre, Amsterdam, The Netherlands </aff>
        <aff id="Aff3"><label>3</label>Institute of Human Genetics, University of Newcastle upon Tyne, Newcastle upon Tyne, UK </aff>
        <aff id="Aff4"><label>4</label>Department of Pediatric Nephrology, H&#xF4;pital Robert Debr&#xE9;, Assistance Publique-H&#xF4;pitaux de Paris, Universit&#xE9; Paris 7, France </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>7</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>24</day>
        <month>7</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2011</year>
      </pub-date>
      <volume>26</volume>
      <issue>1</issue>
      <fpage>155</fpage>
      <lpage>157</lpage>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>6</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>8</day>
          <month>6</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>6</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2010</copyright-statement>
      </permissions>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; IPNA 2010</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Sirs,</p>
    <p>The oldest of three sisters, two of whom are monozygous twins, presenting all with atypical hemolytic uremic syndrome (aHUS) associated with a <italic>CFH</italic> mutation, was referred at the age of 3&#xA0;years to the Emma Children&#x2019;s Hospital/Academic Medical Centre of Amsterdam (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. She never recovered renal function and commenced peritoneal dialysis. Bilateral nephrectomy was performed 1 year later because of hypertension. She lost two transplants by recurrence, one immediately posttransplantation and the other one 2&#xA0;months posttransplant despite preventive plasma exchanges (PEs) contemporary to frequency reduction of PE. From the age of 15&#xA0;years, she began to experience transient sensory and motor symptoms on both sides of her body associated with low blood pressure (BP) during hemodialysis. Magnetic resonance angiogram (MRA) showed severe stenoses of both middle and both anterior cerebral arteries (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>) (partial report in [<xref ref-type="bibr" rid="CR3">3</xref>]). She did not present any additional risk factors for developing arteriosclerosis (such as long-duration hypertension, diabetes, uncontrolled hyperparathyroidism). No arterial calcification and no left ventricular hypertrophy were shown.
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Clinical course in patient and her twin sisters</p></caption><graphic xlink:href="467_2010_1608_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Three-Tesla magnetic resonance images (MRIs) of patient 2 (<bold>a</bold>, <bold>b</bold>) and her sister (<bold>c</bold>). Coronal 3D time-of flight (TOF) MRA maximum intensity projection (MIP) (<bold>a</bold>) image of patient at the age of 15 years demonstrates (near) occlusion of the M1 segment of the right middle cerebral artery (<italic>thick arrow</italic>) and the A1 segment of the right anterior cerebral artery (<italic>long arrow</italic>), and severe stenosis of the M1 segment of the left middle cerebral artery (<italic>thick arrow</italic>) and the A1 segment of the left anterior cerebral artery (<italic>long arrow</italic>). Axial fluid-attenuated inversion recovery (FLAIR) MRI (<bold>b</bold>) of the patient at the age of 17 years shows infarct in right middle and anterior cerebral arteries. Coronal 3D TOF MRA MIP image (<bold>c</bold>) of the sister of patient 2 at the age of 14 years shows normal appearance of intracranial arteries. Basilar artery and side branches were manually removed from the 3D data sets in <bold>a</bold> and <bold>c</bold> to better demonstrate the anterior cerebral arteries</p></caption><graphic xlink:href="467_2010_1608_Fig2_HTML" id="MO2"/></fig></p>
    <p>At the age of 17&#xA0;years, the patient was transplanted for the third time under pre- and postoperative prophylactic PEs [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Postoperatively, she developed infarcts in the right frontal and frontoparietal regions (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>). She recovered almost completely. Ten months after transplantation, the child developed bronchospasm and hypotension during PE. For this reason, she was switched to eculizumab [<xref ref-type="bibr" rid="CR2">2</xref>]. Under this treatment, she presented no HUS recurrence, and renal function remained stable (plasma creatinine 120&#xA0;&#x3BC;mol/L) 16&#xA0;months after PE discontinuation. The first of her twin sisters (twin 1) developed aHUS at the age of 5.3&#xA0;years. She required chronic dialysis despite initial daily PE for 10&#xA0;days and three intermittent courses of fresh frozen plasma (FFP) infusions. Two years later, she received a cadaver renal transplant under PE prophylaxis. At 7.5&#xA0;years follow-up, the graft function is satisfactory (serum creatinine 137&#xA0;&#x3BC;mol). The second twin (twin 2) presented aHUS at the age of 5.8&#xA0;years (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>) [<xref ref-type="bibr" rid="CR1">1</xref>]. She was treated immediately with daily PE and, following remission, with one PE every 2&#xA0;weeks to this time. At 9.5&#xA0;years after HUS onset, native renal function (serum creatinine 49&#xA0;&#x3BC;mol/L) was normal. MRA showed normal cerebral vasculature in both twins at age 14 years (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2c</xref>). Contrary to their older sister with cerebral artery stenoses who was treated by prophylactic PE for 2&#xA0;months only, the twin sisters received prophylactic PE without interruption for, respectively, 7.5 (twin 1) and 9&#xA0;(twin 2) years.</p>
    <p>Although brain ischemia sometimes resulting in cerebral infarct is observed in aHUS, stenosis of large vessels has been reported in aHUS only once&#x2014;in a child presenting with a Lys350Asp gain of function <italic>CFB</italic> mutation [<xref ref-type="bibr" rid="CR4">4</xref>]. Of note, this patient, as ours, was dialyzed for long periods from the age of 4&#xA0;months. At the age of 10&#xA0;years, she started having episodes of bilateral hemiparesis during hemodialysis in relation with multiple stenoses of cerebral arteries. Stenoses of large arteries have never been reported as a complication of renal replacement therapy (RRT) in children [<xref ref-type="bibr" rid="CR5">5</xref>]. Chronic continuous complement dysregulation might contribute to vascular lesions. Indeed complement activation occurs both in human and experimental atherosclerosis, and the deposition of C5b-9 correlates with disease state [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
    <p>Our patient and the patient reported recently by Loirat et al. [<xref ref-type="bibr" rid="CR4">4</xref>] suggest that aHUS with complement dysregulation, a disease of microvascularization, may also involve large arteries, especially when patients have to face long periods of dialysis when plasma therapy is not used. The latter reports also raise the question of preventing vascular lesions by avoiding complement system disorders. This emphasizes the importance of including patients at an early stage in specific programs of kidney transplantation using preventive plasma therapy or combined liver transplantation. Inhibition of the complement system by anti-C5 antibody that is actually under investigation might be valuable for this purpose in the future [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
  </body>
  <back>
    <ack>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davin</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Strain</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Goodship</surname>
              <given-names>TH</given-names>
            </name>
          </person-group>
          <article-title>Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation</article-title>
          <source>Pediatr Nephrol</source>
          <year>2008</year>
          <volume>23</volume>
          <fpage>1517</fpage>
          <lpage>1521</lpage>
          <pub-id pub-id-type="doi">10.1007/s00467-008-0833-y</pub-id>
          <pub-id pub-id-type="pmid">18483746</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davin</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Gracchi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bouts</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Groothoff</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Strain</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Goodship</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation</article-title>
          <source>Am J Kidney Dis</source>
          <year>2009</year>
          <volume>55</volume>
          <fpage>708</fpage>
          <lpage>711</lpage>
          <pub-id pub-id-type="doi">10.1053/j.ajkd.2009.08.011</pub-id>
          <pub-id pub-id-type="pmid">19854549</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vergouwen</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Adriani</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Roos</surname>
              <given-names>YB</given-names>
            </name>
            <name>
              <surname>Groothoff</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Majoie</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
          <article-title>Proximal cerebral artery stenosis in a patient with haemolytic uremic syndrome</article-title>
          <source>Am J Neuroradiol</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>e34</fpage>
          <pub-id pub-id-type="doi">10.3174/ajnr.A0965</pub-id>
          <pub-id pub-id-type="pmid">18258702</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loirat</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Macher</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Elmaleh-Berges</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Desch&#xEA;nes</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Goodship</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Majoie</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Davin</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Blanc</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Savatovsky</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Moret</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fremeaux-Bacchi</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Non-atheromatous arterial stenoses in atypical haemolytic uremic syndrome associated with complement dysregulation</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2010</year>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Mitsnefes</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management</article-title>
          <source>Am J Kidney Dis</source>
          <year>2009</year>
          <volume>54</volume>
          <fpage>345</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="doi">10.1053/j.ajkd.2009.04.027</pub-id>
          <pub-id pub-id-type="pmid">19619845</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haskard</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Mason</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>The role of complement in atherosclerosis</article-title>
          <source>Curr Opin Lipidol</source>
          <year>2008</year>
          <volume>19</volume>
          <fpage>478</fpage>
          <lpage>482</lpage>
          <pub-id pub-id-type="doi">10.1097/MOL.0b013e32830f4a06</pub-id>
          <pub-id pub-id-type="pmid">18769228</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
